You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Related products

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-Agpat2 antibody (ab21816)

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-Agpat2 antibody
See all Agpat2 products (3) ...

Description

Mouse polyclonal to Agpat2

Tested applications

WBmore details

Cross reactivity

Reacts with

Mouse

Predicted to work with

Human

Immunogen

Fusion protein: LLRHGGRTVDNMSIISWFVR, corresponding to amino acids 49/68 of Mouse Agpat2.

LLRHGGRTVD NMSIISWFVR

General notes

Produced from outbred CD1 mice

Properties

Form

Liquid

Storage instructions

Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze / thaw cycles.

Storage buffer

Constituents: 50% Glycerol

Purity

Whole antiserum

Primary antibody notes

This antibody was raised by a genetic immunization technique. Genetic immunization can be used to generate antibodies by directly delivering antigen-coding DNA into the animal, rather than injecting a protein or peptide (Tang et al.PubMed: 1545867; Chambers and Johnston PubMed: 12910245; Barry and Johnston PubMed: 9234514). The animal`s cells produce the protein, which stimulates the animal`s immune system to produce antibodies against that particular protein. A vector coding for a partial fusion protein was used for genetic immunisation of a mouse and the resulting serum was tested in Western blot against an E.coli lysate containing that partial fusion protein. Genetic immunization offers enormous advantages over the traditional protein-based immunization method. DNA is faster, cheaper and easier to produce and can be produced by standard techniques readily amenable to automation. Furthermore, the antibodies generated by genetic immunization are usually of superior quality with regard to specificity, affinity and recognizing the native protein.

Clonality

Polyclonal

Isotype

IgG

  • Western blot - Agpat2 antibody (ab21816)Western blot - Agpat2 antibody (ab21816) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab21816 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application notes

WB: 1/1000. Predicted molecular weight: 31 kDa.

Not tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.

This antibody has been tested in Western blot against an E.coli lysate containing the partial recombinant fusion protein used as an immunogen. We have no data on detection of endogenous protein.

Target

Function

Converts lysophosphatidic acid (LPA) into phosphatidic acid by incorporating an acyl moiety at the sn-2 position of the glycerol backbone.

Tissue specificity

Expressed predominantly in heart and liver.

Pathway

Phospholipid metabolism; CDP-diacylglycerol biosynthesis; CDP-diacylglycerol from sn-glycerol 3-phosphate: step 2/3.

Involvement in disease

Defects in AGPAT2 are the cause of congenital generalized lipodystrophy type 1 (CGL1) [MIM:608594]; also known as Berardinelli-Seip congenital lipodystrophy type 1 (BSCL1) or Berardinelli-Seip syndrome. CGL1 is an autosomal recessive disorder characterized by marked paucity of adipose tissue, extreme insulin resistance, hypertriglyceridemia, hepatic steatosis and early onset of diabetes.

Sequence similarities

Belongs to the 1-acyl-sn-glycerol-3-phosphate acyltransferase family.

Domain

The HXXXXD motif is essential for acyltransferase activity and may constitute the binding site for the phosphate moiety of the glycerol-3-phosphate.

Cellular localization

Membrane.

Target information above from: UniProt accessionO15120 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • 1 acyl sn glycerol 3 phosphate acyltransferase beta antibody
  • 1 acylglycerol 3 phosphate O acyltransferase 2 antibody
  • 1 AGP acyltransferase 2 antibody
  • 1 AGPAT2 antibody
  • 1-acyl-sn-glycerol-3-phosphate acyltransferase beta antibody
  • 1-acylglycerol-3-phosphate O-acyltransferase 2 antibody
  • 1-AGP acyltransferase 2 antibody
  • 1-AGPAT 2 antibody
  • Agpat2 antibody
  • Berardinelli Seip congenital lipodystrophy antibody
  • BSCL antibody
  • BSCL1 antibody
  • EC 2.3.1.51 antibody
  • LPAAB antibody
  • LPAAT beta antibody
  • LPAAT-beta antibody
  • Lysophosphatidic acid acyltransferase beta antibody
  • Lysophosphatidic acid acyltransferase-beta antibody
  • PLCB_HUMAN antibody
see all

Anti-Agpat2 antibody images:

  Western blot - Agpat2 antibody (ab21816)

Western blot - Agpat2 antibody (ab21816)

All lanes : Anti-Agpat2 antibody (ab21816) at 1/1000 dilution

Lane 1 : Total protein extract from E. coli with ~50ng to 100ng of a negative control fusion protein with an irrelevant antigen at 20 ug
Lane 2 : Total protein extract from E. coli with ~50ng to 500ng of the antigen fusion protein at 20 ug

Secondary
Rabbit anti-mouse IgG + IgM, (H+L) horseradish peroxidase conjugated at 1/5000 dilution

Predicted band size : 31 kDa


The molecular weight of the band on the western blot does not correspond to the predicted band size above (predicted from the molecular weight of the natural protein) because of the additional mass of the fusion and because the fusion protein only contains a partial fragment of the gene.

References for Anti-Agpat2 antibody (ab21816)

ab21816 has not yet been referenced specifically in any publications.

Publishing research using ab21816? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"